These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 31870626)

  • 21. Complement activation in Hidradenitis suppurativa: Covert low-grade inflammation or innocent bystander?
    van Straalen KR; Dudink K; Aarts P; van der Zee HH; van den Bosch TPP; Giang J; Prens EP; Damman J
    Front Immunol; 2022; 13():953674. PubMed ID: 36211440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Innate immunity and microbial dysbiosis in hidradenitis suppurativa - vicious cycle of chronic inflammation.
    Chopra D; Arens RA; Amornpairoj W; Lowes MA; Tomic-Canic M; Strbo N; Lev-Tov H; Pastar I
    Front Immunol; 2022; 13():960488. PubMed ID: 35967376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pyoderma gangrenosum: proposed pathogenesis and current use of biologics with an emphasis on complement C5a inhibitor IFX-1.
    Lu JD; Milakovic M; Ortega-Loayza AG; Marzano AV; Alavi A
    Expert Opin Investig Drugs; 2020 Nov; 29(11):1179-1185. PubMed ID: 32880206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The critical role of macrophages in the pathogenesis of hidradenitis suppurativa.
    Shah A; Alhusayen R; Amini-Nik S
    Inflamm Res; 2017 Nov; 66(11):931-945. PubMed ID: 28656364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High inflammation in hidradenitis suppurativa extends to perilesional skin and can be subdivided by lipocalin-2 expression.
    Navrazhina K; Garcet S; Zheng X; Hur HB; Frew JW; Krueger JG
    J Allergy Clin Immunol; 2022 Jan; 149(1):135-144.e12. PubMed ID: 34081946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Surface Microbiome of Clinically Unaffected Skinfolds in Hidradenitis Suppurativa: A Cross-Sectional Culture-Based and 16S rRNA Gene Amplicon Sequencing Study in 60 Patients.
    Riverain-Gillet É; Guet-Revillet H; Jais JP; Ungeheuer MN; Duchatelet S; Delage M; Lam T; Hovnanian A; Nassif A; Join-Lambert O
    J Invest Dermatol; 2020 Sep; 140(9):1847-1855.e6. PubMed ID: 32339539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered Skin and Gut Microbiome in Hidradenitis Suppurativa.
    McCarthy S; Barrett M; Kirthi S; Pellanda P; Vlckova K; Tobin AM; Murphy M; Shanahan F; O'Toole PW
    J Invest Dermatol; 2022 Feb; 142(2):459-468.e15. PubMed ID: 34364884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrating the skin and blood transcriptomes and serum proteome in hidradenitis suppurativa reveals complement dysregulation and a plasma cell signature.
    Hoffman LK; Tomalin LE; Schultz G; Howell MD; Anandasabapathy N; Alavi A; Suárez-Fariñas M; Lowes MA
    PLoS One; 2018; 13(9):e0203672. PubMed ID: 30265680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Skin immunity and its dysregulation in atopic dermatitis, hidradenitis suppurativa and vitiligo.
    Campione E; Lanna C; Diluvio L; Cannizzaro MV; Grelli S; Galluzzo M; Talamonti M; Annicchiarico-Petruzzelli M; Mancini M; Melino G; Candi E; Schiavone G; Wang Y; Shi Y; Bianchi L
    Cell Cycle; 2020 Feb; 19(3):257-267. PubMed ID: 31905036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dysregulated cytokine expression in lesional and nonlesional skin in hidradenitis suppurativa.
    Kelly G; Hughes R; McGarry T; van den Born M; Adamzik K; Fitzgerald R; Lawlor C; Tobin AM; Sweeney CM; Kirby B
    Br J Dermatol; 2015 Dec; 173(6):1431-9. PubMed ID: 26282467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gluteal hidradenitis suppurativa presenting pemphigus-like findings: case report.
    Kurihara Y; Furue M
    BMC Dermatol; 2019 Jul; 19(1):11. PubMed ID: 31337387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inflammatory Mechanisms in Hidradenitis Suppurativa.
    Kelly G; Prens EP
    Dermatol Clin; 2016 Jan; 34(1):51-8. PubMed ID: 26617358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bacterial biofilm is associated with higher levels of regulatory T cells in unaffected hidradenitis suppurativa skin.
    Kjaersgaard Andersen R; Ring HC; Kallenbach K; Eriksen JO; Jemec GBE
    Exp Dermatol; 2019 Mar; 28(3):312-316. PubMed ID: 30657613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Skin and Gut Microbiome in Hidradenitis Suppurativa: Current Understanding and Future Considerations for Research and Treatment.
    Luck ME; Tao J; Lake EP
    Am J Clin Dermatol; 2022 Nov; 23(6):841-852. PubMed ID: 36116091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apocrine Gland-Rich Skin Has a Non-Inflammatory IL-17-Related Immune Milieu, that Turns to Inflammatory IL-17-Mediated Disease in Hidradenitis Suppurativa.
    Jenei A; Dajnoki Z; Medgyesi B; Gáspár K; Béke G; Kinyó Á; Méhes G; Hendrik Z; Dinya T; Törőcsik D; Zouboulis CC; Prens EP; Bíró T; Szegedi A; Kapitány A
    J Invest Dermatol; 2019 Apr; 139(4):964-968. PubMed ID: 30391261
    [No Abstract]   [Full Text] [Related]  

  • 36. Complement in kidney disease: core curriculum 2015.
    Thurman JM
    Am J Kidney Dis; 2015 Jan; 65(1):156-68. PubMed ID: 25441433
    [No Abstract]   [Full Text] [Related]  

  • 37. The Role of the Cutaneous Microbiome in Hidradenitis Suppurativa-Light at the End of the Microbiological Tunnel.
    Langan EA; Recke A; Bokor-Billmann T; Billmann F; Kahle BK; Zillikens D
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32054085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeted treatments for hidradenitis suppurativa: a review of the current literature and ongoing clinical trials.
    Maarouf M; Clark AK; Lee DE; Shi VY
    J Dermatolog Treat; 2018 Aug; 29(5):441-449. PubMed ID: 29098911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The IL-1 Pathway Is Hyperactive in Hidradenitis Suppurativa and Contributes to Skin Infiltration and Destruction.
    Witte-Händel E; Wolk K; Tsaousi A; Irmer ML; Mößner R; Shomroni O; Lingner T; Witte K; Kunkel D; Salinas G; Jodl S; Schmidt N; Sterry W; Volk HD; Giamarellos-Bourboulis EJ; Pokrywka A; Döcke WD; Schneider-Burrus S; Sabat R
    J Invest Dermatol; 2019 Jun; 139(6):1294-1305. PubMed ID: 30528824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complement in glomerular diseases.
    Tan Y; Zhao MH
    Nephrology (Carlton); 2018 Oct; 23 Suppl 4():11-15. PubMed ID: 30298653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.